Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HIV-1 induction of tolerogenic dendritic cells is mediated by cellular interaction with suppressive T cells. | Front Immunol | 2022 | 36032117 | PubTator, text mining | PubMed |
| Deciphering colorectal cancer immune microenvironment transcriptional landscape on single cell resolution - A role for immunotherapy. | Front Immunol | 2022 | 36032085 | PubTator, text mining | PubMed |
| Phenotypic, functional, and metabolic heterogeneity of immune cells infiltrating non-small cell lung cancer. | Front Immunol | 2022 | 36032082 | PubTator, text mining | PubMed |
| The cytoplasmic LSm1-7 and nuclear LSm2-8 complexes exert opposite effects on Hepatitis B virus biosynthesis and interferon responses. | Front Immunol | 2022 | 36016928 | PubTator, text mining | PubMed |
| Chemokines in Primary Liver Cancer. | Int J Mol Sci | 2022 | 36012108 | PubTator, text mining | PubMed |
| Chronic Pain after Bone Fracture: Current Insights into Molecular Mechanisms and Therapeutic Strategies. | Brain Sci | 2022 | 36009119 | PubTator, text mining | PubMed |
| HAMP as a Prognostic Biomarker for Colorectal Cancer Based on Tumor Microenvironment Analysis. | Front Oncol | 2022 | 35992796 | PubTator, text mining | PubMed |
| A pan-cancer analysis reveals the genetic alterations and immunotherapy of Piezo2 in human cancer. | Front Genet | 2022 | 35991548 | PubTator, text mining | PubMed |
| Shared and specific biological signalling pathways for diabetic retinopathy, peripheral neuropathy and nephropathy by high-throughput sequencing analysis. | Diab Vasc Dis Res | 2022 | 35989592 | PubTator, text mining | PubMed |
| Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape. | J Transl Med | 2022 | 35986288 | PubTator, text mining | PubMed |
| Protein Regulator of Cytokinesis 1 (PRC1) Upregulation Promotes Immune Suppression in Liver Hepatocellular Carcinoma. | J Immunol Res | 2022 | 35983074 | PubTator, text mining | PubMed |
| Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease. | Front Immunol | 2022 | 35967386 | PubTator, text mining | PubMed |
| Monocarboxylate transporter upregulation in induced regulatory T cells promotes resistance to anti-PD-1 therapy in hepatocellular carcinoma patients. | Front Oncol | 2022 | 35965549 | PubTator, text mining | PubMed |
| MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer. | World J Surg Oncol | 2022 | 35962436 | PubTator, text mining | PubMed |
| Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma. | Front Oncol | 2022 | 35957868 | PubTator, text mining | PubMed |
| NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma. | Front Genet | 2022 | 35957696 | PubTator, text mining | PubMed |
| CCL18 Expression Is Higher in a Glioblastoma Multiforme Tumor than in the Peritumoral Area and Causes the Migration of Tumor Cells Sensitized by Hypoxia. | Int J Mol Sci | 2022 | 35955670 | PubTator, text mining | PubMed |
| Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity. | J Hematol Oncol | 2022 | 35948909 | PubTator, text mining | PubMed |
| Implications of regulatory T cells in non-lymphoid tissue physiology and pathophysiology. | Front Immunol | 2022 | 35936011 | PubTator, text mining | PubMed |
| Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer. | Front Immunol | 2022 | 35935941 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=29